AP NEWS

US Wet Age-Related Macular Degeneration Market and Competitive Landscape 2018 - ResearchAndMarkets.com

October 10, 2018

DUBLIN--(BUSINESS WIRE)--Oct 10, 2018--The “US Wet Age-Related Macular Degeneration Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

US Wet Age-Related Macular Degeneration Market and Competitive Landscape - 2018 provides comprehensive insights into Wet Age-Related Macular Degeneration pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Wet Age-Related Macular Degeneration market size and drug sales. This research also provides insights into Wet Age-Related Macular Degeneration epidemiology and late stage pipeline.

The research is classified into following sections - Wet Age-Related Macular Degeneration overview with definitions, symptoms, etiology, diagnosis, treatment options; Wet Age-Related Macular Degeneration pipeline insights covering late stage clinical trials pipeline; Wet Age-Related Macular Degeneration prevalence trends by countries; Wet Age-Related Macular Degeneration market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.

Research Scope:

Wet Age-Related Macular Degeneration pipeline: Find out the drugs in clinical trials for Wet Age-Related Macular Degeneration by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company Wet Age-Related Macular Degeneration epidemiology: Find out the prevalence of Wet Age-Related Macular Degeneration in US; prevalence forecast to 2023 Wet Age-Related Macular Degeneration products: Identify key products marketed and prescribed for Wet Age-Related Macular Degeneration by brand name, by molecule, by company, by branded / generic, in US Wet Age-Related Macular Degeneration market size: Find out the market size for Wet Age-Related Macular Degeneration drugs in US; Find out how the market advanced from 2014 Wet Age-Related Macular Degeneration drug sales: Find out the sales of Wet Age-Related Macular Degeneration drugs in US Wet Age-Related Macular Degeneration drugs sales forecast: Sales forecast for Wet Age-Related Macular Degeneration drugs to 2023 in US Wet Age-Related Macular Degeneration market share analysis: Find out the market shares of Wet Age-Related Macular Degeneration drugs and outlook in US

For more information about this report visit https://www.researchandmarkets.com/research/6sgpvv/us_wet?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181010005833/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Optical Disorders Drugs

KEYWORD: UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH OPTICAL PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/10/2018 01:07 PM/DISC: 10/10/2018 01:07 PM

http://www.businesswire.com/news/home/20181010005833/en

AP RADIO
Update hourly